Is Blood Indexed in PubMed? Yes, and It Sits in the Core Clinical Set

Blood papers often need to reach more than one hematology audience at once:

• clinicians
• leukemia and lymphoma researchers
• coagulation and thrombosis readers
• transplant groups
• translational hematology teams

Those readers frequently search by disease, lineage, biomarker, transplant problem, or treatment question rather than by browsing the journal issue. PubMed indexing is part of how a Blood paper enters that real search workflow.

This journal is a useful example because the record carries an extra signal:

• PubMed means the paper is discoverable in the standard biomedical search environment.
• MEDLINE means the journal is actively inside the curated NLM journal index.
• Core clinical journals (AIM) means the journal also sits in the clinical subset historically treated as especially important for frontline medical use.

For Blood, that helps explain why the journal functions as more than a narrow specialty outlet.

This page answers the discoverability question. It does not answer whether the manuscript is broad enough or important enough for Blood.

Indexing tells you the paper will be visible. It does not tell you whether the study has the field-level hematology consequence this journal expects.

That is why the better next reads are:

• Is Blood a good journal?
• Blood submission guide
• Blood submission process
• Blood acceptance rate

Yes, Blood is indexed in PubMed and currently indexed for MEDLINE, and the core-clinical-journals signal makes the indexing story even stronger.

If your question is whether a published paper will be visible inside the main hematology and clinical-literature workflow, the answer is yes. If your real question is whether the manuscript belongs in Blood, that is a separate fit judgment. A free Manusights scan is the best next step if you want that call before submission.